A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

September 13, 2024

Study Completion Date

September 19, 2024

Conditions

Erosive EsophagitisHeartburnSymptomatic Nonerosive Gasroesophageal Reflux DiseaseHelicobacter Pylori Infection

Interventions

DRUG

Vonoprazan

Oral tablet.

Trial Locations (1)

PPD Development, LP, Las Vegas